15 results on '"Bibollet-Ruche, Frederic"'
Search Results
2. Hybrid Origin of SIV in Chimpanzees
- Author
-
Bailes, Elizabeth, Gao, Feng, Bibollet-Ruche, Frederic, Courgnaud, Valerie, Peeters, Martine, Marx, Preston A., Hahn, Beatrice H., and Sharp, Paul M.
- Published
- 2003
3. SIVcpz in Wild Chimpanzees
- Author
-
Santiago, Mario L., Rodenburg, Cynthia M., Kamenya, Shadrack, Bibollet-Ruche, Frederic, Gao, Feng, Bailes, Elizabeth, Meleth, Sreelatha, Soong, Seng-Jaw, Kilby, J. Michael, Moldoveanu, Zina, Fahey, Babette, Muller, Martin N., Ayouba, Ahidjo, Nerrienet, Eric, McClure, Harold M., Heeney, Jonathan L., Pusey, Anne E., Collins, D. Anthony, Boesch, Christophe, Wrangham, Richard W., Goodall, Jane, Sharp, Paul M., Shaw, George M., and Hahn, Beatrice H.
- Published
- 2002
4. CD4 receptor diversity in chimpanzees protects against SIV infection.
- Author
-
Bibollet-Ruche, Frederic, Russell, Ronnie M., Weimin Liu, Stewart-Jones, Guillaume B. E., Sherrill-Mix, Scott, Yingying Li, Learn, Gerald H., Smith, Andrew G., Gondim, Marcos V. P., Plenderleith, Lindsey J., Decker, Julie M., Easlick, Juliet L., Wetzel, Katherine S., Collman, Ronald G., Shilei Ding, Finzi, Andrés, Ayouba, Ahidjo, Peeters, Martine, Leendertz, Fabian H., and Schijndel, Joost van
- Subjects
- *
SIMIAN immunodeficiency virus , *HIV , *CHIMPANZEES , *GENE transfection , *PHENOTYPES , *MUTAGENESIS - Abstract
Human and simian immunodeficiency viruses (HIV/SIVs) use CD4 as the primary receptor to enter target cells. Here, we show that the chimpanzee CD4 is highly polymorphic, with nine coding variants present in wild populations, and that this diversity interferes with SIV envelope (Env)-CD4 interactions. Testing the replication fitness of SIVcpz strains in CD4+ T cells from captive chimpanzees, we found that certain viruses were unable to infect cells from certain hosts. These differences were recapitulated in CD4 transfection assays, which revealed a strong association between CD4 genotypes and SIVcpz infection phenotypes. The most striking differences were observed for three substitutions (Q25R, Q40R, and P68T), with P68T generating a second N-linked glycosylation site (N66) in addition to an invariant N32 encoded by all chimpanzee CD4 alleles. In silico modeling and site-directed mutagenesis identified charged residues at the CD4-Env interface and clashes between CD4- and Env-encoded glycans as mechanisms of inhibition. CD4 polymorphisms also reduced Env-mediated cell entry of monkey SIVs, which was dependent on at least one D1 domain glycan. CD4 allele frequencies varied among wild chimpanzees, with high diversity in all but the western subspecies, which appeared to have undergone a selective sweep. One allele was associated with lower SIVcpz prevalence rates in the wild. These results indicate that substitutions in the D1 domain of the chimpanzee CD4 can prevent SIV cell entry. Although some SIVcpz strains have adapted to utilize these variants, CD4 diversity is maintained, protecting chimpanzees against infection with SIVcpz and other SIVs to which they are exposed. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
5. CHIIMP: An automated high‐throughput microsatellite genotyping platform reveals greater allelic diversity in wild chimpanzees.
- Author
-
Barbian, Hannah J., Connell, Andrew Jesse, Avitto, Alexa N., Russell, Ronnie M., Smith, Andrew G., Gundlapally, Madhurima S., Shazad, Alexander L., Li, Yingying, Bibollet‐Ruche, Frederic, Wroblewski, Emily E., Mjungu, Deus, Lonsdorf, Elizabeth V., Stewart, Fiona A., Piel, Alexander K., Pusey, Anne E., Sharp, Paul M., and Hahn, Beatrice H.
- Subjects
CHIMPANZEES ,MICROSATELLITE repeats ,ALLELES ,SPECIES diversity ,GENOTYPES ,SHORT tandem repeat analysis - Abstract
Abstract: Short tandem repeats (STRs), also known as microsatellites, are commonly used to noninvasively genotype wild‐living endangered species, including African apes. Until recently, capillary electrophoresis has been the method of choice to determine the length of polymorphic STR loci. However, this technique is labor intensive, difficult to compare across platforms, and notoriously imprecise. Here we developed a MiSeq‐based approach and tested its performance using previously genotyped fecal samples from long‐term studied chimpanzees in Gombe National Park, Tanzania. Using data from eight microsatellite loci as a reference, we designed a bioinformatics platform that converts raw MiSeq reads into locus‐specific files and automatically calls alleles after filtering stutter sequences and other PCR artifacts. Applying this method to the entire Gombe population, we confirmed previously reported genotypes, but also identified 31 new alleles that had been missed due to sequence differences and size homoplasy. The new genotypes, which increased the allelic diversity and heterozygosity in Gombe by 61% and 8%, respectively, were validated by replicate amplification and pedigree analyses. This demonstrated inheritance and resolved one case of an ambiguous paternity. Using both singleplex and multiplex locus amplification, we also genotyped fecal samples from chimpanzees in the Greater Mahale Ecosystem in Tanzania, demonstrating the utility of the MiSeq‐based approach for genotyping nonhabituated populations and performing comparative analyses across field sites. The new automated high‐throughput analysis platform (available at https://github.com/ShawHahnLab/chiimp) will allow biologists to more accurately and effectively determine wildlife population size and structure, and thus obtain information critical for conservation efforts. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
6. Loss of CXCR6 coreceptor usage characterizes pathogenic lentiviruses.
- Author
-
Wetzel, Katherine S., Yi, Yanjie, Yadav, Anjana, Bauer, Anya M., Bello, Ezekiel A., Romero, Dino C., Bibollet-Ruche, Frederic, Hahn, Beatrice H., Paiardini, Mirko, Silvestri, Guido, Peeters, Martine, and Collman, Ronald G.
- Subjects
HIV ,LENTIVIRUSES ,GENE expression ,LYMPHOCYTES ,PRIMATES - Abstract
Pandemic HIV-1 originated from the cross-species transmission of SIVcpz, which infects chimpanzees, while SIVcpz itself emerged following the cross-species transmission and recombination of monkey SIVs, with env contributed by the SIVgsn/mus/mon lineage that infects greater spot-nosed, mustached and mona monkeys. SIVcpz and HIV-1 are pathogenic in their respective hosts, while the phenotype of their SIVgsn/mus/mon ancestors is unknown. However, two well-studied SIV infected natural hosts, sooty mangabeys (SMs) and African green monkeys (AGMs), typically remain healthy despite high viral loads; these species express low levels of the canonical coreceptor CCR5, and recent work shows that CXCR6 is a major coreceptor for SIV in these hosts. It is not known what coreceptors were used by the precursors of SIVcpz, whether coreceptor use changed during emergence of the SIVcpz/HIV-1 lineage, and what T cell subsets express CXCR6 in natural hosts. Using species-matched coreceptors and CD4, we show here that SIVcpz uses only CCR5 for entry and, like HIV-1, cannot use CXCR6. In contrast, SIVmus efficiently uses both CXCR6 and CCR5. Coreceptor selectivity was determined by Env, with CXCR6 use abrogated by Pro326 in the V3 crown, which is absent in monkey SIVs but highly conserved in SIVcpz/HIV-1. To characterize which cells express CXCR6, we generated a novel antibody that recognizes CXCR6 of multiple primate species. Testing lymphocytes from SM, the best-studied natural host, we found that CXCR6 is restricted to CD4+ effector memory cells, and is expressed by a sub-population distinct from those expressing CCR5. Thus, efficient CXCR6 use, previously identified in SM and AGM infection, also characterizes a member of the SIV lineage that gave rise to SIVcpz/HIV-1. Loss of CXCR6 usage by SIVcpz may have altered its cell tropism, shifting virus from CXCR6-expressing cells that may support replication without disrupting immune function or homeostasis, towards CCR5-expressing cells with pathogenic consequences. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
7. Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee.
- Author
-
Barbian, Hannah J., Jackson-Jewett, Raven, Brown, Corrine S., Bibollet-Ruche, Frederic, Learn, Gerald H., Decker, Timothy, Kreider, Edward F., Yingying Li, Denny, Thomas N., Sharp, Paul M., Shaw, George M., Lifson, Jeffrey, Acosta, Edward P., Saag, Michael S., Bar, Katharine J., and Hahn, Beatrice H.
- Subjects
SIMIAN immunodeficiency virus ,IMMUNODEFICIENCY ,CHIMPANZEES ,HIV ,DISEASES ,HEALTH ,DIAGNOSIS - Abstract
Background: Simian immunodeficiency virus of chimpanzees (SIVcpz), the progenitor of human immunodeficiency virus type 1 (HIV-1), is associated with increased mortality and AIDS-like immunopathology in wild-living chimpanzees (Pan troglodytes). Surprisingly, however, similar findings have not been reported for chimpanzees experimentally infected with SIVcpz in captivity, raising questions about the intrinsic pathogenicity of this lentivirus. Findings: Here, we report progressive immunodeficiency and clinical disease in a captive western chimpanzee (P. t. verus) infected twenty years ago by intrarectal inoculation with an SIVcpz strain (ANT) from a wild-caught eastern chimpanzee (P. t. schweinfurthii). With sustained plasma viral loads of 10
5 to 106 RNA copies/ml for the past 15 years, this chimpanzee developed CD4+ T cell depletion (220 cells/μl), thrombocytopenia (90,000 platelets/μl), and persistent soft tissue infections refractory to antibacterial therapy. Combination antiretroviral therapy consisting of emtricitabine (FTC), tenofovir disoproxil fumarate (TDF), and dolutegravir (DTG) decreased plasma viremia to undetectable levels (<200 copies/ml), improved CD4+ T cell counts (509 cell/μl), and resulted in the rapid resolution of all soft tissue infections. However, initial lack of adherence and/or differences in pharmacokinetics led to low plasma drug concentrations, which resulted in transient rebound viremia and the emergence of FTC resistance mutations (M184V/I) identical to those observed in HIV-1 infected humans. Conclusions: These data demonstrate that SIVcpz can cause immunodeficiency and other hallmarks of AIDS in captive chimpanzees, including P. t. verus apes that are not naturally infected with this virus. Moreover, SIVcpz-associated immunodeficiency can be effectively treated with antiretroviral therapy, although sufficiently high plasma concentrations must be maintained to prevent the emergence of drug resistance. These findings extend a growing body of evidence documenting the immunopathogenicity of SIVcpz and suggest that experimentally infected chimpanzees may benefit from clinical monitoring and therapeutic intervention. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
8. The Role of the Antiviral APOBEC3 Gene Family in Protecting Chimpanzees against Lentiviruses from Monkeys.
- Author
-
Etienne, Lucie, Bibollet-Ruche, Frederic, Sudmant, Peter H., Wu, Lily I., Hahn, Beatrice H., and Emerman, Michael
- Subjects
- *
GENES , *GENOMES , *CHIMPANZEES , *PAN (Mammals) , *LENTIVIRUSES - Abstract
Cross-species transmissions of viruses from animals to humans are at the origin of major human pathogenic viruses. While the role of ecological and epidemiological factors in the emergence of new pathogens is well documented, the importance of host factors is often unknown. Chimpanzees are the closest relatives of humans and the animal reservoir at the origin of the human AIDS pandemic. However, despite being regularly exposed to monkey lentiviruses through hunting, chimpanzees are naturally infected by only a single simian immunodeficiency virus, SIVcpz. Here, we asked why chimpanzees appear to be protected against the successful emergence of other SIVs. In particular, we investigated the role of the chimpanzee APOBEC3 genes in providing a barrier to infection by most monkey lentiviruses. We found that most SIV Vifs, including Vif from SIVwrc infecting western-red colobus, the chimpanzee’s main monkey prey in West Africa, could not antagonize chimpanzee APOBEC3G. Moreover, chimpanzee APOBEC3D, as well as APOBEC3F and APOBEC3H, provided additional protection against SIV Vif antagonism. Consequently, lentiviral replication in primary chimpanzee CD4+ T cells was dependent on the presence of a lentiviral vif gene that could antagonize chimpanzee APOBEC3s. Finally, by identifying and functionally characterizing several APOBEC3 gene polymorphisms in both common chimpanzees and bonobos, we found that these ape populations encode APOBEC3 proteins that are uniformly resistant to antagonism by monkey lentiviruses. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
9. Reacquisition of Nef-Mediated Tetherin Antagonism in a Single In Vivo Passage of HIV-1 through Its Original Chimpanzee Host.
- Author
-
Götz, Nicola, Sauter, Daniel, Usmani, Shariq M., Fritz, Joëlle V., Goffinet, Christine, Heigele, Anke, Geyer, Matthias, Bibollet-Ruche, Frederic, Learn, Gerald H., Fackler, Oliver T., Hahn, Beatrice H., and Kirchhoff, Frank
- Subjects
DRUG antagonism ,HIV ,CHIMPANZEES ,INFECTIOUS disease transmission ,INTERFERONS ,LENTIVIRUSES - Abstract
Summary: The interferon-induced host restriction factor tetherin poses a barrier for SIV transmission from primates to humans. After cross-species transmission, the chimpanzee precursor of pandemic HIV-1 switched from the accessory protein Nef to Vpu to effectively counteract human tetherin. As we report here, the experimental reintroduction of HIV-1 into its original chimpanzee host resulted in a virus that can use both Vpu and Nef to antagonize chimpanzee tetherin. Functional analyses demonstrated that alterations in and near the highly conserved ExxxLL motif in the C-terminal loop of Nef were critical for the reacquisition of antitetherin activity. Strikingly, just two amino acid changes allowed HIV-1 Nef to counteract chimpanzee tetherin and promote virus release. Our data demonstrate that primate lentiviruses can reacquire lost accessory gene functions during a single in vivo passage and suggest that other functional constraints keep Nef ready to regain antitetherin activity. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
10. The Quality of Chimpanzee T-Cell Activation and Simian Immunodeficiency Virus/Human Immunodeficiency Virus Susceptibility Achieved via Antibody-Mediated T-Cell Receptor/CD3 Stimulation Is a Function of the Anti-CD3 Antibody Isotype.
- Author
-
Bibollet-Ruche, Frederic, McKinney, Brett A., Duverger, Alexandra, Wagner, Frederic H., Ansari, Aftab A., and Kutsch, Olaf
- Subjects
- *
T cells , *CHIMPANZEES , *IMMUNODEFICIENCY , *SIMIAN viruses , *HIV , *VIRAL antibodies - Abstract
While human immunodeficiency virus type 1 (HIV-1) infection is associated with hyperimmune activation and systemic depletion of CD4+ T cells, simian immunodeficiency virus (SIV) infection in sooty mangabeys or chimpanzees does not exhibit these hallmarks. Control of immune activation is thought to be one of the major components that govern species-dependent differences in the disease pathogenesis. A previous study introduced the idea that the resistance of chimpanzees to SIVcpz infection-induced hyperimmune activation could be the result of the expression of select sialic acid-recognizing immunoglobulin (Ig)-like lectin (Siglec) superfamily members by chimpanzee T cells. Siglecs, which are absent on human T cells, were thought to control levels of T-cell activation in chimpanzees and were thus suggested as a cause for the pathogenic differences in the course of SIVcpz or HIV-1 infection. As in human models of T-cell activation, stimulation had been attempted using an anti-CD3 monoclonal antibody (MAb) (UCHT1; isotype IgG1), but despite efficient binding, UCHT1 failed to activate chimpanzee T cells, an activation block that could be partially overcome by MAb-induced Siglec-5 internalization. We herein demonstrate that anti-CD3 MAb-mediated chimpanzee T-cell activation is a function of the anti-CD3 MAb isotype and is not governed by Siglec expression. While IgG1 anti-CD3 MAbs fail to stimulate chimpanzee T cells, IgG2a anti-CD3 MAbs activate chimpanzee T cells in the absence of Siglec manipulations. Our results thus imply that prior to studying possible differences between human and chimpanzee T-cell activation, a relevant model of chimpanzee T cell activation needs to be established. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
11. Molecular Ecology and Natural History of Simian Foamy Virus Infection in Wild-Living Chimpanzees.
- Author
-
Weimin Liu, Worobey, Michael, Yingying Li, Keele, Brandon F., Bibollet-Ruche, Frederic, Yuanyuan Guo, Goepfert, Paul A., Santiago, Mario L., Ndjango, Jean-Bosco N., Neel, Cecile, Clifford, Stephen L., Sanz, Crickette, Kamenya, Shadrack, Wilson, Michael L., Pusey, Anne E., Gross-Camp, Nicole, Boesch, Christophe, Smith, Vince, Zamma, Koichiro, and Huffman, Michael A.
- Subjects
EBOLA virus disease ,ZOONOSES ,PRIMATE diseases ,HIV ,CHIMPANZEES - Abstract
Identifying microbial pathogens with zoonotic potential in wild-living primates can be important to human health, as evidenced by human immunodeficiency viruses types 1 and 2 (HIV-1 and HIV-2) and Ebola virus. Simian foamy viruses (SFVs) are ancient retroviruses that infect Old and New World monkeys and apes. Although not known to cause disease, these viruses are of public health interest because they have the potential to infect humans and thus provide a more general indication of zoonotic exposure risks. Surprisingly, no information exists concerning the prevalence, geographic distribution, and genetic diversity of SFVs in wild-living monkeys and apes. Here, we report the first comprehensive survey of SFVcpz infection in free-ranging chimpanzees (Pan troglodytes) using newly developed, fecal-based assays. Chimpanzee fecal samples (n = 724) were collected at 25 field sites throughout equatorial Africa and tested for SFVcpzspecific antibodies (n = 706) or viral nucleic acids (n = 392). SFVcpz infection was documented at all field sites, with prevalence rates ranging from 44% to 100%. In two habituated communities, adult chimpanzees had significantly higher SFVcpz infection rates than infants and juveniles, indicating predominantly horizontal rather than vertical transmission routes. Some chimpanzees were co-infected with simian immunodeficiency virus (SIVcpz); however, there was no evidence that SFVcpz and SIVcpz were epidemiologically linked. SFVcpz nucleic acids were recovered from 177 fecal samples, all of which contained SFVcpz RNA and not DNA. Phylogenetic analysis of partial gag (616 bp), pol-RT (717 bp), and pol-IN (425 bp) sequences identified a diverse group of viruses, which could be subdivided into four distinct SFVcpz lineages according to their chimpanzee subspecies of origin. Within these lineages, there was evidence of frequent superinfection and viral recombination. One chimpanzee was infected by a foamy virus from a Cercopithecus monkey species, indicating cross-species transmission of SFVs in the wild. These data indicate that SFVcpz (i) is widely distributed among all chimpanzee subspecies; (ii) is shed in fecal samples as viral RNA; (iii) is transmitted predominantly by horizontal routes; (iv) is prone to superinfection and recombination; (v) has co-evolved with its natural host; and (vi) represents a sensitive marker of population structure that may be useful for chimpanzee taxonomy and conservation strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
12. Amplification of a Complete Simian Immunodeficiency Virus Genome from Fecal RNA of a Wild Chimpanzee.
- Author
-
Santiago, Mario L., Bibollet-Ruche, Frederic, Bailes, Elizabeth, Kamenya, Shadrack, Muller, Martin N., Lukasik, Magdalena, Pusey, Anne E., Collins, D. Anthony, Wrangham, Richard W., Goodall, Jane, Shaw, George M., Sharp, Paul M., and Hahn, Beatrice H.
- Subjects
- *
SIMIAN viruses , *HIV , *CHIMPANZEES , *DISEASES - Abstract
Current knowledge of the genetic diversity of simian immunodeficiency virus (SIVcpz) infection of wild chimpanzees (Pan troglodytes) is incomplete since few isolates, mostly from captive apes from Cameroon and Gabon, have been characterized; yet this information is critical for understanding the origins of human immunodeficiency virus type 1 (HIV-1) and the circumstances leading to the HIV-1 pandemic. Here, we report the first full-length SIVcpz sequence (TAN1) from a wild chimpanzee (Pan troglodytes schweinfurthii) from Gombe National Park (Tanzania), which was obtained noninvasively by amplification of virion RNA from fecal samples collected under field conditions. Using reverse transcription-PCR and a combination of generic and strain-specific primers, we amplified 13 subgenomic fragments which together spanned the entire TAN1 genome (9,326 bp). Distance and phylogenetic tree analyses identified TAN1 unambiguously as a member of the HIV-1/SIVcpz group of viruses but also revealed an extraordinary degree of divergence from all previously characterized SIVcpz and HIV-1 strains. In Gag, Poi, and Env proteins, TAN1 differed from west-central African SIVcpz and HIV-1 strains on average by 36, 30, and 51% of amino acid sequences, respectively, approaching distance values typically found for SIVs from different primate species. The closest relative was SIVcpzANT, also from a P. t. schweinfurthii ape, which differed by 30, 25, and 44%, respectively, in these same protein sequences but clustered with TANI in all major coding regions in a statistically highly significant manner. These data indicate that east African chimpanzees, like those from west-central Africa, are naturally infected by SIVcpz but that their viruses comprise a second, divergent SIVcpz lineage which appears to have evolved in relative isolation for an extended period of time. Our data also demonstrate that noninvasive molecular epidemiological studies of SIVcpz in wild chimpanzees are feasible and... [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
13. Nef Proteins from Simian Immunodeficiency Virus-Infected Chimpanzees Interact with p21-Activated Kinase 2 and Modulate Cell Surface Expression of Various Human Receptors.
- Author
-
Kirchhoff, Frank, Schindler, Michael, Bailer, Nicola, Renkema, G. Herma, Saksela, Kalle, Knoop, Volker, Müller-Trutwin, Michaela C., Santiago, Mario L., Bibollet-Ruche, Frederic, Dittmar, Matthias T., Heeney, Jonathan L., Hahn, Beatrice H., and Münch, Jan
- Subjects
- *
PROTEINS , *SIMIAN viruses , *HIV , *MAJOR histocompatibility complex , *PROTEIN-protein interactions , *CHIMPANZEES , *VIROLOGY - Abstract
The accessory Nef protein allows human immunodeficiency virus type 1 (HIV-1) to persist at high levels and to cause AIDS in infected humans. The function of HIV-1 group M subtype B nef alleles has been extensively studied, and a variety of in vitro activities believed to he important for viral pathogenesis have been established. However, the function of nef alleles derived from naturally simian immunodeficiency virus (SIV)-infected chimpanzees, the original host of HIV-1, or from the HIV-1 N and O groups resulting from independent zoonotic transmissions remains to he investigated. In the present study we demonstrate that SIVcpz and HIV-1 group N or O nef alleles down-modulate CD4, CD28, and class I or II MHC molecules and up-regulate surface expression of the invariant chain (Ii) associated with immature major histocompatibility complex (MHC) class II. Furthermore, the ability of Nef to interact with the p21-activated kinase 2 was generally conserved. The functional activity of HIV-1 group N and O nef genes did not differ significantly from group M nef alleles. However, SIVcpz nef genes as a group showed a 1.8- and 2.0-fold-higher activity in modulating CD28 (P = 0.0002) and Ii (P = 0.016) surface expression, respectively, but were 1.7-fold less active in down-regulating MHC class II molecules (P = 0.006) compared to HIV-1 M nef genes. Our finding that primary SIVcpz nef alleles derived from naturally infected chimpanzees modulate the surface expression of various human cellular receptors involved in T-cell activation and antigen presentation suggests that functional nef genes helped the chimpanzee virus to persist efficiently in infected humans immediately after zoonotic transmission. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
14. Foci of Endemic Simian Immunodeficiency Virus Infection in Wild-Living Eastern Chimpanzees (Pan troglodytes schweinfurthii).
- Author
-
Santiago, Mario L., Lukasik, Magdalena, Kamenya, Shadrack, Yingying Li, Bibollet-Ruche, Frederic, Bailes, Elizabeth, Muller, Martin N., Emery, Melissa, Goldenberg, David A., Lwanga, Jeremiah S., Ayouba, Ahidjo, Nerrienet, Eric, McClure, Harold M., Heeney, Jonathan L., Watts, David P., Pusey, Anne E., Collins, D. Anthony, and Wrangham, Richard W.
- Subjects
- *
SIMIAN viruses , *CHIMPANZEES - Abstract
Examines the prevalence of the simian immunodeficiency virus of chimpanzees (SIVcpz) infection in wild Pan troglodytes schweinfurthii communities in East Africa. Basis for the wide variability in SIVcpz infection rates; Estimated prevalence of SIVcpz infection; Infection rates.
- Published
- 2003
- Full Text
- View/download PDF
15. Eastern Chimpanzees, but Not Bonobos, Represent a Simian Immunodeficiency Virus Reservoir.
- Author
-
Yingying Li, Ndjango, Jean-Bosco, Learn, Gerald H., Ramirez, Miguel A., Keele, Brandon F., Bibollet-Ruche, Frederic, Weimin Liu, Easlick, Juliet L., Decker, Julie M., Rudicell, Rebecca S., Inogwabini, Bila-Isia, Ahuka-Mundeke, Steve, Leendertz, Fabian H., Reynolds, Vernon, Muller, Martin N., Chancellor, Rebecca L., Rundus, Aaron S., Simmons, Nicole, Worobey, Michael, and Shaw, George M.
- Subjects
- *
SIMIAN immunodeficiency virus diseases , *CHIMPANZEES , *NONINVASIVE diagnostic tests , *COLONIZATION (Ecology) , *RNA viruses , *DISEASES - Abstract
Chimpanzees in west central Africa (Pan troglodytes troglodytes) are endemically infected with simian immunodeficiency viruses (SIVcpzPtt) that have crossed the species barrier to humans and gorillas on at least five occasions, generating pandemic and nonpandemic forms of human immunodeficiency virus type 1 (HIV-1) as well as gorilla SIV (SIVgor). Chimpanzees in east Africa (Pan troglodytes schweinfurthii) are also infected with SIVcpz; however, their viruses (SIVcpzPts) have never been found in humans. To examine whether this is due to a paucity of natural infections, we used noninvasive methods to screen wild-living eastern chimpanzees in the Democratic Republic of the Congo (DRC), Uganda, and Rwanda. We also screened bonobos (Pan paniscus) in the DRC, a species not previously tested for SIV in the wild. Fecal samples (n = 3,108) were collected at 50 field sites, tested for species and subspecies origin, and screened for SIVcpz antibodies and nucleic acids. Of 2,565 samples from eastern chimpanzees, 323 were antibody positive and 92 contained viral RNA. The antibody-positive samples represented 76 individuals from 19 field sites, all sampled north of the Congo River in an area spanning 250,000 km2. In this region, SIVcpzPts was common and widespread, with seven field sites exhibiting infection rates of 30% or greater. The overall prevalence of SIVcpzPts infection was 13.4% (95% confidence interval, 10.7% to 16.5%). In contrast, none of the 543 bonobo samples from six sites was antibody positive. All newly identified SIVcpzPts strains clustered in strict accordance to their subspecies origin; however, they exhibited considerable genetic diversity, especially in protein domains known to be under strong host selection pressure. Thus, the absence of SIVcpzPts zoonoses cannot be explained by an insufficient primate reservoir. Instead, greater adaptive hurdles may have prevented the successful colonization of humans by P. t. schweinfurthii viruses. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.